CN Patent

CN121335887A — 含氮芳环化合物及其医药用途

Assigned to Siegershenko Shenzhen Co ltd · Expires 2026-01-13 · 0y expired

What this patent protects

本申请涉及一种式I所示化合物、含有这类化合物的组合物以及该类化合物的医药用途。本申请的化合物对癌症、肺动脉高压、病理性血管生成具有较好的治疗效果。

USPTO Abstract

本申请涉及一种式I所示化合物、含有这类化合物的组合物以及该类化合物的医药用途。本申请的化合物对癌症、肺动脉高压、病理性血管生成具有较好的治疗效果。

Drugs covered by this patent

Patent Metadata

Patent number
CN121335887A
Jurisdiction
CN
Classification
—
Expires
2026-01-13
Drug substance claim
No
Drug product claim
No
Assignee
Siegershenko Shenzhen Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.